|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09606 DUALITYBIO-B
Nominal 
180.700 -2.800 (-1.526%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
6
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | -3,980.00 RMB (cts) | |
| Net Profit | -2,594.83 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | -411.16 | -454.00 | 0 | -- | 258.00 | -1,232.00 |
| 2027 | -353.95 | -403.50 | 0 | -- | -175.00 | -1,242.00 |
| 2028 | -783.00 | -865.00 | 0 | -- | -379.87 | -1,191.30 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 258.00 | 302.00 | -- | MORGAN STANLEY | Overweight | 493.00 | 02/04/2026 | |
| 2026 | -365.00 | -405.00 | -- | HAITONG | OutPerform | 457.74 | 09/04/2026 | |
| 2026 | -360.00 | -400.00 | -- | CICC | Outperform | 430.00 | 26/03/2026 | |
| 2026 | -457.32 | -503.00 | -- | SOOCHOW SEC | Buy | 418.61 | 07/07/2026 | |
| 2026 | -1,232.00 | -1,361.00 | -- | UBS | Buy | 318.00 | 30/08/2026 | |
| 2026 | -1,085.80 | -1,190.00 | -- | CMB INT'L SEC | Buy | 284.50 | 01/09/2026 | |
| 2027 | -350.90 | -411.00 | -- | MORGAN STANLEY | -- | -- | 02/04/2026 | |
| 2027 | -175.00 | -194.00 | -- | HAITONG | -- | -- | 09/04/2026 | |
| 2027 | -357.00 | -396.00 | -- | CICC | -- | -- | 26/03/2026 | |
| 2027 | -296.43 | -326.00 | -- | SOOCHOW SEC | -- | -- | 07/07/2026 | |
| 2027 | -891.00 | -984.00 | -- | UBS | -- | -- | 30/08/2026 | |
| 2027 | -1,242.00 | -1,362.00 | -- | CMB INT'L SEC | -- | -- | 01/09/2026 | |
| 2028 | -379.87 | -418.00 | -- | SOOCHOW SEC | -- | -- | 07/07/2026 | |
| 2028 | -783.00 | -865.00 | -- | UBS | -- | -- | 30/08/2026 | |
| 2028 | -1,191.30 | -1,305.00 | -- | CMB INT'L SEC | -- | -- | 01/09/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 04/09/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -917,545 |
| %Change | -55.757% |
| EPS / (LPS) | RMB -10.200 |
| NBV Per Share (¥) | RMB 16.022 |